2022-08-12 |
2022-08-11 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
1,678,954
+24.1%
10.07
16,907,067
USD
|
1,678,954
+24.1%
|
10.07
|
16,907,067
USD
|
|
2022-08-11 |
2022-08-10 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
4,012
+0.1%
10.07
40,401
USD
|
4,012
+0.1%
|
10.07
|
40,401
USD
|
|
2022-05-20 |
2022-05-18 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
477,824
+5.8%
5.57
2,661,002
USD
|
477,824
+5.8%
|
5.57
|
2,661,002
USD
|
|
2022-01-07 |
2022-01-06 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
300,000
+3.8%
6.31
1,894,410
USD
|
300,000
+3.8%
|
6.31
|
1,894,410
USD
|
|
2022-01-07 |
2022-01-05 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
250,000
+3.2%
6.30
1,574,650
USD
|
250,000
+3.2%
|
6.30
|
1,574,650
USD
|
|
2021-12-16 |
2021-12-16 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
146,685
+2.2%
7.07
1,037,752
USD
|
146,685
+2.2%
|
7.07
|
1,037,752
USD
|
|
2021-12-15 |
2021-12-15 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
180,744
+2.7%
6.77
1,223,637
USD
|
180,744
+2.7%
|
6.77
|
1,223,637
USD
|
|
2021-12-15 |
2021-12-14 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
94,103
+1.4%
6.81
640,936
USD
|
94,103
+1.4%
|
6.81
|
640,936
USD
|
|
2021-12-15 |
2021-12-13 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
187,391
+3.0%
7.08
1,326,803
USD
|
187,391
+3.0%
|
7.08
|
1,326,803
USD
|
|
2021-12-10 |
2021-12-10 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
768,171
+13.8%
7.18
5,511,627
USD
|
768,171
+13.8%
|
7.18
|
5,511,627
USD
|
|
2021-12-10 |
2021-12-09 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
264,644
+5.0%
7.58
2,007,087
USD
|
264,644
+5.0%
|
7.58
|
2,007,087
USD
|
|
2021-12-10 |
2021-12-08 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
560,691
+11.8%
8.02
4,497,078
USD
|
560,691
+11.8%
|
8.02
|
4,497,078
USD
|
|
2021-10-01 |
2021-09-29 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
100,000
+1.3%
12.95
1,294,500
USD
|
100,000
+1.3%
|
12.95
|
1,294,500
USD
|
|
2021-03-09 |
2021-03-05 |
PS
Planned sale
|
Chopas James George
Principal Finance Accounting
Officer
|
370
-5.2%
20.88
7,726
USD
|
370
-5.2%
|
20.88
|
7,726
USD
|
|
2021-02-26 |
2021-02-25 |
S
Sale
|
Grausso Sal
Chief Commercial Officer
Officer
|
1,322
-10.1%
18.93
25,025
USD
|
1,322
-10.1%
|
18.93
|
25,025
USD
|
|
2020-11-09 |
2020-11-05 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
100,000
+1.4%
14.26
1,426,230
USD
|
100,000
+1.4%
|
14.26
|
1,426,230
USD
|
|
2020-09-16 |
2020-09-14 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
200,000
+2.8%
11.69
2,338,680
USD
|
200,000
+2.8%
|
11.69
|
2,338,680
USD
|
|
2020-09-14 |
2020-09-11 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
199,029
+2.9%
11.33
2,255,118
USD
|
199,029
+2.9%
|
11.33
|
2,255,118
USD
|
|
2020-07-09 |
2020-07-08 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
25,000
+0.4%
13.21
330,178
USD
|
25,000
+0.4%
|
13.21
|
330,178
USD
|
|
2020-05-04 |
2020-04-30 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
50,000
+0.7%
15.75
787,555
USD
|
50,000
+0.7%
|
15.75
|
787,555
USD
|
|
2020-02-28 |
2020-02-26 |
PS
Planned sale
|
Hughes Owen
Non-Executive Director
|
2,750
-20.5%
17.95
49,363
USD
|
2,750
-20.5%
|
17.95
|
49,363
USD
|
|
2020-02-28 |
2020-02-26 |
S
Sale
|
Carmona Jose
Chief Financial Officer
Officer
|
1,292
-2.7%
17.93
23,169
USD
|
1,292
-2.7%
|
17.93
|
23,169
USD
|
|
2020-02-28 |
2020-02-26 |
PS
Planned sale
|
Dere Willard H
Non-Executive Director
|
1,925
-13.6%
17.95
34,554
USD
|
1,925
-13.6%
|
17.95
|
34,554
USD
|
|
2020-02-28 |
2020-02-26 |
S
Sale
|
Morris Charles Q
Chief Medical Officer
Officer
|
1,256
-3.6%
17.93
22,524
USD
|
1,256
-3.6%
|
17.93
|
22,524
USD
|
|
2020-02-28 |
2020-02-26 |
PS
Planned sale
|
Rosenberg Anthony
Non-Executive Director
|
1,815
-12.8%
17.95
32,579
USD
|
1,815
-12.8%
|
17.95
|
32,579
USD
|
|
2020-02-28 |
2020-02-26 |
S
Sale
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
Officer
|
889
-3.6%
17.93
15,942
USD
|
889
-3.6%
|
17.93
|
15,942
USD
|
|
2019-11-08 |
2019-11-06 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
100,000
+1.5%
23.00
2,300,300
USD
|
100,000
+1.5%
|
23.00
|
2,300,300
USD
|
|
2019-07-03 |
2019-07-01 |
PS
Planned sale
|
Rosenberg Anthony
|
1,584
-15.4%
24.60
38,966
USD
|
1,584
-15.4%
|
24.60
|
38,966
USD
|
|
2019-06-11 |
2019-06-07 |
B
Purchase
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
|
2,500
+50.0%
21.81
54,536
USD
|
2,500
+50.0%
|
21.81
|
54,536
USD
|
|
2019-05-13 |
2019-05-10 |
B
Purchase
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
|
2,000
+66.7%
21.43
42,860
USD
|
2,000
+66.7%
|
21.43
|
42,860
USD
|
|
2019-04-18 |
2019-04-16 |
PS
Planned sale
|
Dere Willard H
|
1,680
-16.3%
22.22
37,330
USD
|
1,680
-16.3%
|
22.22
|
37,330
USD
|
|
2019-04-18 |
2019-04-16 |
PS
Planned sale
|
Graves Kurt
|
4,800
-46.6%
22.32
107,136
USD
|
4,800
-46.6%
|
22.32
|
107,136
USD
|
|
2019-04-18 |
2019-04-16 |
PS
Planned sale
|
Hughes Owen
|
2,400
-23.3%
22.22
53,328
USD
|
2,400
-23.3%
|
22.22
|
53,328
USD
|
|
2019-04-12 |
2019-04-11 |
PS
Planned sale
|
Roychowdhury Debasish
|
4,800
-46.6%
22.15
106,320
USD
|
4,800
-46.6%
|
22.15
|
106,320
USD
|
|
2019-03-06 |
2019-03-05 |
B
Purchase
|
Hopfield Jessica
|
12,800
+inf%
19.23
246,190
USD
|
12,800
+inf%
|
19.23
|
246,190
USD
|
|
2018-12-21 |
2018-12-20 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+0.9%
14.48
868,782
USD
|
60,000
+0.9%
|
14.48
|
868,782
USD
|
|
2018-12-18 |
2018-12-17 |
B
Purchase
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
Officer
|
3,000
+inf%
15.71
47,130
USD
|
3,000
+inf%
|
15.71
|
47,130
USD
|
|
2018-12-17 |
2018-12-14 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+0.9%
15.64
938,256
USD
|
60,000
+0.9%
|
15.64
|
938,256
USD
|
|
2018-08-22 |
2018-08-20 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+0.9%
19.65
1,178,808
USD
|
60,000
+0.9%
|
19.65
|
1,178,808
USD
|
|
2018-08-16 |
2018-08-15 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
69,363
+1.1%
20.78
1,441,530
USD
|
69,363
+1.1%
|
20.78
|
1,441,530
USD
|
|
2018-08-16 |
2018-08-14 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
100,000
+1.6%
20.87
2,086,880
USD
|
100,000
+1.6%
|
20.87
|
2,086,880
USD
|
|
2018-08-10 |
2018-08-08 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+1.0%
22.73
1,363,884
USD
|
60,000
+1.0%
|
22.73
|
1,363,884
USD
|
|
2018-07-30 |
2018-07-27 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.8%
24.81
1,240,605
USD
|
50,000
+0.8%
|
24.81
|
1,240,605
USD
|
|
2018-07-26 |
2018-07-25 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.8%
27.28
1,363,805
USD
|
50,000
+0.8%
|
27.28
|
1,363,805
USD
|
|
2018-06-13 |
2018-06-11 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.8%
27.36
1,367,835
USD
|
50,000
+0.8%
|
27.36
|
1,367,835
USD
|
|
2018-05-24 |
2018-05-23 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
40,000
+0.7%
28.91
1,156,320
USD
|
40,000
+0.7%
|
28.91
|
1,156,320
USD
|
|
2018-05-23 |
2018-05-21 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+1.0%
29.27
1,756,380
USD
|
60,000
+1.0%
|
29.27
|
1,756,380
USD
|
|
2018-04-23 |
2018-04-19 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
40,000
+0.7%
33.80
1,351,936
USD
|
40,000
+0.7%
|
33.80
|
1,351,936
USD
|
|
2018-04-09 |
2018-04-05 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
36.58
1,828,845
USD
|
50,000
+0.9%
|
36.58
|
1,828,845
USD
|
|
2018-03-06 |
2018-03-02 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
80,000
+1.4%
32.52
2,601,448
USD
|
80,000
+1.4%
|
32.52
|
2,601,448
USD
|
|
2018-02-12 |
2018-02-09 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
75,000
+1.3%
34.38
2,578,763
USD
|
75,000
+1.3%
|
34.38
|
2,578,763
USD
|
|
2017-11-16 |
2017-11-14 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
26.25
1,312,390
USD
|
50,000
+0.9%
|
26.25
|
1,312,390
USD
|
|
2017-11-13 |
2017-11-10 |
B
Purchase
|
Hatzis-Schoch Brent
Sr. VP, General Counsel
|
1,778
+355.6%
28.09
49,943
USD
|
1,778
+355.6%
|
28.09
|
49,943
USD
|
|
2017-11-07 |
2017-11-07 |
B
Purchase
|
Hoiland Jesper
President and CEO
Executive Director
|
6,800
+111.5%
29.04
197,450
USD
|
6,800
+111.5%
|
29.04
|
197,450
USD
|
|
2017-11-07 |
2017-11-03 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
29.15
1,457,575
USD
|
50,000
+0.9%
|
29.15
|
1,457,575
USD
|
|
2017-10-27 |
2017-10-26 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
30.95
1,547,550
USD
|
50,000
+0.9%
|
30.95
|
1,547,550
USD
|
|
2017-10-26 |
2017-10-25 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
32.85
1,642,415
USD
|
50,000
+0.9%
|
32.85
|
1,642,415
USD
|
|
2017-09-15 |
2017-09-15 |
B
Purchase
|
Hoiland Jesper
President and CEO
Executive Director
|
6,100
+inf%
32.72
199,608
USD
|
6,100
+inf%
|
32.72
|
199,608
USD
|
|
2017-09-15 |
2017-09-14 |
B
Purchase
|
Carmona Jose
Chief Financial Officer
|
3,000
+inf%
32.83
98,503
USD
|
3,000
+inf%
|
32.83
|
98,503
USD
|
|
2017-09-15 |
2017-09-14 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
32.94
1,647,225
USD
|
50,000
+0.9%
|
32.94
|
1,647,225
USD
|
|
2017-09-15 |
2017-09-13 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
100,000
+1.9%
33.71
3,370,750
USD
|
100,000
+1.9%
|
33.71
|
3,370,750
USD
|
|
2017-09-13 |
2017-09-12 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
35.42
1,770,820
USD
|
50,000
+0.9%
|
35.42
|
1,770,820
USD
|
|
2017-09-07 |
2017-09-05 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+1.0%
36.75
1,837,625
USD
|
50,000
+1.0%
|
36.75
|
1,837,625
USD
|
|
2017-08-18 |
2017-08-16 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+1.2%
35.98
2,158,536
USD
|
60,000
+1.2%
|
35.98
|
2,158,536
USD
|
|
2017-08-11 |
2017-08-10 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
75,000
+1.5%
34.26
2,569,500
USD
|
75,000
+1.5%
|
34.26
|
2,569,500
USD
|
|
2017-08-11 |
2017-08-09 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
75,000
+1.5%
35.67
2,675,528
USD
|
75,000
+1.5%
|
35.67
|
2,675,528
USD
|
|
2017-05-31 |
2017-05-30 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
40,000
+0.8%
34.21
1,368,348
USD
|
40,000
+0.8%
|
34.21
|
1,368,348
USD
|
|
2017-05-30 |
2017-05-25 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
40,000
+0.8%
36.25
1,450,020
USD
|
40,000
+0.8%
|
36.25
|
1,450,020
USD
|
|
2017-05-22 |
2017-05-18 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+1.0%
34.41
1,720,345
USD
|
50,000
+1.0%
|
34.41
|
1,720,345
USD
|
|
2017-05-18 |
2017-05-17 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
18,000
+0.4%
32.98
593,662
USD
|
18,000
+0.4%
|
32.98
|
593,662
USD
|
|
2017-05-18 |
2017-05-16 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
17,000
+0.3%
33.93
576,725
USD
|
17,000
+0.3%
|
33.93
|
576,725
USD
|
|
2017-05-16 |
2017-05-12 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
15,000
+0.3%
34.00
509,996
USD
|
15,000
+0.3%
|
34.00
|
509,996
USD
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+1.0%
35.93
1,796,480
USD
|
50,000
+1.0%
|
35.93
|
1,796,480
USD
|
|
2017-05-09 |
2017-05-08 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
22,800
+0.5%
35.60
811,630
USD
|
22,800
+0.5%
|
35.60
|
811,630
USD
|
|
2017-05-09 |
2017-05-05 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
20,600
+0.4%
35.55
732,283
USD
|
20,600
+0.4%
|
35.55
|
732,283
USD
|
|